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Abstract 
The Drosophila embryonic nervous system develops from an array of neural precursor cells called, 
neuroblasts. These neuroblasts give rise to all the cell types that populate the mature central nervous 
system (CNS). The CNS originates from a bilateraly symmetric neurectoderm that is subdivided into 
three domains along the dorso-ventral (DV) axis. One of these domains is defined by the expression of 
the Homeodomain protein ventral nervous system defective (vnd). Regulation of neuroblast designation 
is very precise and controlled. Extensive research has been done on neuroblast formation along the 
anteroposterior axis, most of which indicates that neuroblast selection within a cluster of 
neurectodermal cells is controlled by segmentation genes. However, much more research is required to 
elucidate the function of genes along the DV axis. Early studies indicate that vnd is required for 
neuroblast formation in the ventral column. Here, we show that vnd function, but not expression, is 
dependent on MAPK activity downstream of Drosophila EGF-R (DER). Specifically, we show that vnd 
activity is eliminated in EGF-R mutant embryos in a stage specific manner by evaluating vnd’s ability to 
inhibit intermediate neuroblast defective (ind), muscle segment homeobox (msh), and the newly 
identified neural tube development player, neu3. Finally, we show that DER functionality in the ventral 
column is entirely dependent on the processing protein rhomboid (rho) in later stage embryos.  
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Chapter 1 
Introduction/Literature Review 
Early embryonic patterning 
During early Drosophila embryogenesis, several cell determination signals specify different tissue types. 
One of these tissues is the neuroectoderm which gives rise to neural progenitor cells, called neuroblasts. 
These cells must have proper directionality, timing, and cellular properties to develop into a working 
spinal cord. In essence, the embryo must develop a bilateral neurectoderm domain with precise 
boundaries within each subdomain. Of the three subdomains, each encodes a different homeodomain 
containing transcription factor: ventral nervous system defective (vnd), intermediate nueroblast 
defective (ind), and muscle segment homeobox (msh) (Chu et al., 1998; Isshiki et al., 1997; Mc Donald et 
al., 1998; Weiss et al., 1998). These three subdomains run the length of the anterior-posterior (AP) axis 
and are bilaterally symmetric along the dorsoventral (DV) axis. The neurectoderm forms along the 
ventral midline and expand dorsally as well as anteriorly/posteriorly. This process is highly regulated 
using a variety of cellular and transcriptional signals.  In vertebrates, complications in this process can 
give rise to a variety of congenital neurological disorders due to the highly conserved nature of the 
system. 
Ventral nerve cord development begins with the designation of proneural clusters. These clusters are 
determined by the expression patterns of the Acheate-scute complex (A-SC) genes. Certain levels of A-SC 
expression, along with other pro-neural genes, among them the pair-rule genes, create a cluster of cells 
that all can become neuroblasts although only one will do so (Skeath, et. al. 1994). The cell that 
expresses the highest level of A-SC will form the new neuroblast. Once the neuroblast has formed, cell 
nonautonomous genes are expressed that laterally inhibit proneural genes in neighboring cells, 
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preventing the formation of other neuroblasts (Skeath, et al. 1994) through the Notch pathway (Skeath. 
1998). 
Researchers have done extensive work in Drosophila nervous system development along the AP axis. 
The A-SC is an essential complex in designating proneural clusters along the AP axis (Skeath. 1998). A-SC 
genes are uniquely expressed in S1 and S2 neural clusters early in development (McDonald, et al. 1998) 
and appear to designate cell clusters as proneural clusters. However, complete a-sc knockouts show that 
only 25% of the neuroblast clusters are lost (Skeath and Doe, 1996). This indicates that other proneural 
genes must also have a role in designating neural clusters. One such gene is the DV gene vnd. This gene 
affects A-SC expression at alternating neuroblast clusters along the AP axis (Skeath et al., 
1994)(McDonald, et al. 1998). Without vnd, AS-C is not expressed within the ventral column which 
clearly indicates that vnd is required for AS-C activation in the ventral column. Tandem vnd; A-SC 
deletions result in the loss of up to 50% of all neuroblast clusters most of which are in the ventral 
column (Skeath et al., 1994)(McDonald, et al. 1998). This indicates that vnd and A-SC share a similar or 
parallel function in neuroblast formation.  
 
Subdivision of the neurectoderm 
vnd is the most ventral of three bilateral DV-axis genes (from ventral to dorsal): vnd, intermediate 
neuroblast defective (ind), and muscle segment homeobox (msh) (Chu et al., 1998; Isshiki et al., 1997; Mc 
Donald et al., 1998; Weiss et al., 1998). Each of these genes has repressive, cell nonautonomous 
features that help determine the precise patterning of each gene within a column (Figure 1A). 
Establishing each of these domains requires two steps. First, vnd is activated by Dorsal, an NF-ĸB like 
transcription factor, and ind/msh are activated by some unknown mechanism. Mitogen Activated 
Protein Kinase (MAPK), downstream of the EGF-R, clearly plays a role in ind activation but once a signal 
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has been transduced, the precise activator of ind remains a mystery (Von Ohlen and Doe, 2000). The 
dorsal boundary of the neurectoderm and thus msh expression is established through Dpp repression 
(Von Ohlen and Doe, 2000). Dorsal then represses Dpp on the ventral border allowing msh to express 
properly (Von Ohlen and Doe, 2000). Once the genes are activated, the repression hierarchy is 
established. Repression typically acts ventral to dorsal. For instance, vnd represses ind which in turn 
represses msh (Mc Donald et al., 1998; Von Ohlen and Doe, 2000)(Chu,H. 1998). However, ind can 
repress vnd expression in late stage embryos (data not shown). In wild-type embryos, Dorsal shows a 
decreasing gradient from the mesoderm to the dorsal side of the neurectoderm (reviewed in: 
(Anderson, 1998). EGF-R is evenly expressed in the ventral and intermediate columns of the 
neurectoderm, and Dpp is only expressed in the epidermis because Dorsal represses Dpp expression 
(Skeath, 1998; Yagi et al., 1998)(Von Ohlen,and Doe 2000). When Dorsal is knocked out, Dpp expands 
into the neurectoderm and mesoderm and the tissue transforms into epidermis (D'Alessio and Frasch, 
1996). When the EGF-R is knocked out, ind expression is lost and vnd and msh fill the intermediate 
column (Von Ohlen,and Doe. 2000). It is unknown whether EGF-R expression affects vnd. When vnd is 
knocked out, the ventral domain establishes an intermediate-like column, ind expression is expanded 
into the ventral column, achaete is no longer expressed in the ventral column, and several ventral 
column neuroblasts are lost (Mellerick,et al. 2002a; 2002b). Conversely, when vnd is overexpressed into 
the intermediate column, that column develops a ventral column fate (Mellerick, et al. 2002a; 2002b).  
In this case, ind expression is lost and Ac is over-expressed in the intermediate column ((Mellerick, et al. 
2002a; 2002b), Figure 2).  
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Fig. 1. Schematic of DV axis 
expression patterns. (A) Wild type 
expression patterns. Dorsal 
expression shows a decreasing 
gradient from ventral to dorsal. Dpp 
shows a decreasing gradient from 
dorsal to ventral. EGF-R activity is 
uniform in the ventral and 
intermediate domain of the 
neurectoderm. vnd, ind, and msh all 
show normal expression patterns. (B) 
Dorsal knockout. Mesoderm, vnd, ind,  
EGF-R, and msh expression is lost. The 
epidermis overtakes the DV axis. (C) 
EGF-R knockout. ind expression is lost. 
vnd and msh expand towards the 
intermediate domain to fill the void 
left by ind (Figure developed from 
Von Ohlen and Doe 2000). 
C 
B 
A 
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The expression of vnd, ind, and msh is initially regulated by the precise activity patterns of three 
signaling pathways: Dorsal, Dpp, and the EGF-R (Figure 1B and 1C). Dorsal is primarily active in the 
ventral column with moderate activity in the intermediate column and low activity in the dorsal column 
(Figure 1A). Dpp is just the opposite with high expression in the dorsal epidermis and has a minimal 
effect in the neurectoderm (Figure 1A). The EGF-R is evenly expressed in the ventral and intermediate 
column but is not active in the dorsal column. Dorsal knockouts result in the total loss of the entire 
neurectoderm (Figure 1B). Partly because Dorsal is required for the expression of certain genes like vnd 
and ind (Von Ohlen, Doe. 2000) and also Dorsal prevents Dpp from being expressed in the 
neurectoderm, changing it into epidermis (Von Ohlen, Doe. 2000). Interestingly, even though EGF-R is 
Wild Type vnd-/- Uasvnd/KrGal4 
Fig. 2. In Situ hybridization of 
Drosophila embryos reveals 
stimulatory activity of vnd on 
achaete but repression activity 
on ind. Embryos from wild type 
(A), vnd-/- (B, vnd438), and 
Uasvnd/KrGal4 (C) 
backgrounds are stained for 
achaete expression. Embryos 
from wild type (D), vnd-/- (E, 
vnd438), and Uasvnd/KrGal4 (F) 
backgrounds are stained for 
ind expression. Arrows point 
achaete expression in wildtype 
(A), lack of achaete expression 
in vnd mutants (B), and 
achaete over expression in 
ectopic vnd embryos(C). 
Brackets show areas of 
expansion or inhibition. 
F D E 
A B C 
achaete 
IND 
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active in the vnd domain, EGF-R knockouts do not result in the loss of vnd expression initially (during late 
stages, vnd does depend on EGF-R signaling). It is unknown whether the loss of EGF-R activity changes 
the activity of vnd itself (Von Ohlen, Doe. 2000).  
 
Vnd structure 
The structure and function of the 80 Kd VND and its motifs have been well characterized (Figure 3). 
Residues 154-193 encode one transcriptional repression motif and one activation motif from residues 
293-528. The activation motif consists of a glutamine-rich domain and two acidic domains. VND contains 
an EH-1 domain, or tinman motif. This motif is also found in the vertebrate NKx-2.2 homologue 
(Stepchenko. 2004). This small region is conserved in vertebrates and is known to interact with the co-
repressor, Groucho (Stepchenko. 2004, Zongxin et. al. 2005, and Nirenberg 2004). Interactions between 
Groucho and VND are critical to repressional functions in vivo and remain unclear. Phosphorylation of 
Groucho down regulates its repressional functions in vitro yet phosphorylation of VND appears to be 
vital to VND’s function (Cinnamon,E. 2008, Ze’ev Paroush personal communication). Finally, VND 
contains the DNA binding domain, homeodomain (HD). The HD recognizes the DNA binding sequence 5’-
TCAAGTGG-3’. Note that the HD in VND recognizes a completely different sequence than the HD’s in 
antenapedia transcription factors, making this particular domain unique (Stepchenko. 2004).  
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Fig. 3. VND protein sequence contains several important structural domains. The Repression Domain 
(RD) includes residues 154-193. The EH-1 or tinman region includes residues 198-209. The Activation 
Domain runs from amino acid 293-528 and includes the glutamine rich domain (QD 293-334) and two 
acidic domains (AcD 401-458 and AcD 509-528). The homeodomain (HD) runs from 545-604 and the NK-
2 specific domain (NK-2 SD) includes 631-647. 
 
Nkx2-2 function in vertebrates 
In vertebrates, reverse genetic analysis shows the VND-like protein, Nkx2-2, is vital to forming 
oligodendrocytes in the spinal cord (Cornell,and Von Ohlen. 2000). Oligodendrogenesis is largely 
controlled by the Sonic Hedgehog (Shh)-Notch signaling pathway. In this pathway, Shh expression levels 
control transcription factor expression along the spinal cord (Qi,Y. 2001). These transcription factors 
then dictate the genesis of, among others, neurons, oligodendrocytes, and glial cells. Nkx2-2 is one such 
transcription factor (Cornell, Von Ohlen. 2000). In Nkx2-2 mutant mice, oligodendrocytes fail to form 
properly and intermediate domain proteins such as Olig1 and Olig2 develop ventral-like expression 
patterns (Qi, et al. 2001). These two proteins, related to the olig family from Drosophila, help define the 
pre-oligodendroglial domain along with the receptor for platelet-derived growth factor α.  Although 
oligodendrogenisis is initiated by Shh signaling, it’s these proteins that create the precursor cell 
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domains. Interaction between these proteins and Nkx2.2 create a neurectoderm structure similar to 
that in Drosophila (Cornell and Von Ohlen, 2000). 
The two domains in VND that share sequence homology to Nkx2.2 are the homeodomain and the EH-
1/tinman domain. The tinman domain binds to the universal co-repressor, Groucho (Mellerick and 
Modica, 2002).This co-repressor enhances the weak repression capabilities of VND suggesting that 
Groucho is required for VND-mediated repression in vivo (Zhang H., et. al. 2008). Groucho-mediated 
repression is regulated by EGFR signaling in vivo (Cinnamon, et al. 2008). Phosphorylation of Groucho 
derepresses the activity of the Groucho-protein complex, allowing transcription of the repressed gene to 
continue (Cinnamon, et al. 2008). However, the VND-Groucho complex still has strong repressor activity 
so there must be other mechanisms by which VND repressor function is maintained. This may include 
direct interaction with other co-factors or modifications such as phosphorylation (Zhang et al., 2008).  
 
Vnd interacts with the HMG domain proteins Dichaete and SoxNeuro 
Acting as an antagonist to Groucho is the Sox-family protein Dichaete (Zhao,G. 2002). Dichaete, or fish-
hook, contains the high mobility group DNA interacting domain and acts in parallel to both VND and IND 
functions. In the medial column, Dichaete and VND coordinate to initiate neuroblast formation (Zhao,G. 
2002). Genetic knockouts of dichaete result in severe defects in neuroblast patterning similar to vnd 
knockouts. Double knockouts of vnd; dichaete result in a phenotype (loss of neuroblast cluster 
formation) that is more pronounced than the single mutants (Zhao, et al. 2007) (Overton et al., 2002). 
However, the double knockout shows that the phenotype is three times more profound than what is 
predicted if the two genes operated independently of each other (Zhao, et al. 2007). This genetic 
interaction suggests that dichaete and vnd synergize in establishing the ventral column of neuroblasts 
(Zhao, et al. 2007). A similar interaction is seen between dichaete and ind. Dichaete also has an ortholog, 
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SoxNeuro (SoxN). SoxN is also a member of the Sox-family and contains the DNA interacting domain, 
high mobility group. Loss-of-function SoxN mutants show that neuroblast formation is severely affected 
in the intermediate and lateral columns but not the medial column (Buescher, et al. 2002) (Overton et 
al., 2002). However, Dichaete acts in a parallel pathway to SoxN in the medial column; double mutants 
are indicative of this. SoxN also interacts genetically with vnd and ind (Buescher, et al. 2002) (Overton et 
al., 2002). 
 
Neu3 function in neurogenisis 
Clearly, vnd functions in neuroblast formation within the ventral column, but exactly how remains 
unclear. Many VND targets, including ind, Ac, Odd, Prospero, Huckebein, and msh, have been identified 
(Mc Donald et al., 1998)(Zhang H., et. al., 2008). Recently, a new vnd target has been characterized: 
neu3. neu3 encodes the matrix metalloprotease, Meltrin (Meyer,H. 2010). In mice and insects, Meltrin is 
commonly expressed in the peripheral nervous system, skeletal muscles, and bones (Meyer, et al. 2010). 
Its exact function in neurogenesis is unknown, however. Its expression pattern in Drosophila embryos 
mimics that of ind but neu3 reacts differently than ind when EGF-R signaling is lost (Meyer, et al. 2010). 
In fact, neu3 expression does not change at all in EGF-R mutant embryos (Fig. 4C). Also, recent evidence 
shows that VND represses neu3 expression in the KrGal4 region when vnd is under the control of the 
UAS promoter (Figure 4). This unique feature may make neu3 a good indicator of VND activity in EGF-R 
mutants. 
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EGF-R signaling in neurogensis 
EGF-R signaling in Drosophila controls many developmental and metabolic processes. This signaling 
operates through the receptor tyrosine kinase, Drosophila EGF-R (DER, Skeath. 1998). There are two 
ligands for the DER: spitz and vein. Vein is a secreted signaling protein that directly activates DER 
signaling (Golembo et al., 1999; Schnepp et al., 1996)(Skeath,J.B. 1998). Spitz encodes an inactive 
transmembrane protein that, when cleaved and processed from the membrane, becomes a secreted 
signaling molecule (Lanoue and Jacobs, 1999). Cleavage of Spitz requires the function of an additional 
membrane bound protein, rhomboid (rho) (Lanoue and Jacobs, 1999). rho, vein double mutant embryos 
are phenotypically identical to DER mutant embryos with regards to neurectoderm patterning (Skeath, 
et al. 1994), suggesting that both vein and rho are required for maximal activation of the DER pathway in 
the early embryo. Recent studies show that in early embryonic development, vein and spitz operate in 
Fig. 4. neu3 is regulated by vnd but not EGF. neu3 expression patterns visualized via in situ stain in 
wildtype (A), Uasvnd/KrGal4 mutant embryos (B), and DER mutant embryos (C). Expression of neu3 
is not seen in the Gal4 region of the Uasvnd mutant embryo. Loss of EGFR signaling does not affect 
neu3 expression patterns. Bracket indicates the area of neu3 inhibition 
A B C 
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parallel pathways (Cinnamon,E. 2008). However, later in development, signaling through the EGF-R 
occurs entirely through the rho-spitz pathway (Skeath, et al. 1994). Because ind requires the activity of 
DER to be expressed and maintain that expression, in late stage embryos, ind expression must depend 
on both vein and spitz/rho expression. 
As mentioned earlier, whether VND transcription factor function is affected by EGF-R activity remains 
unknown. In DER mutant embryos neuroblast formation fails to occur in the intermediate column 
(Skeath. 1998). ind expression, a gene that plays a crucial role in intermediate column neuroblast 
formation, is lost in DER mutants (Von Ohlen and Doe, 2000).  Some neuroblast clusters in the medial 
column form incorrectly in DER mutants, indicating that the EGF-R influences neuroblast formation in 
the medial column (Skeath,J.B. 1998). Unlike ind, however, vnd expression is not initially lost in DER 
mutants (Yagi,Y. 1998). It is unclear whether the function of vnd depends on phosphorylation by MAPK 
downstream of the EGF-R. However, Groucho phosphorylation down-regulates its repressive 
capabilities, suggesting that phosphorylation of the Groucho-Vnd complex may reduce vnd’s ability to 
repress target proteins like ind and neu3 (Cai. 2003). This is unlikely, however, considering that the EGFR 
is active in both the ventral and intermediate domain and vnd still represses ind and neu3. It may be that 
Groucho phosphorylation, when bound to vnd, is thwarted by some unknown mechanism controlled by 
a phosphatase. Another possibility is that Groucho cannot be phosphorylated when bound to vnd 
because of conformational restraints. It is also possible that additional modifications or co-factor 
interactions are able to over-ride the reduced Groucho function in the presence of MAPK activity. 
Regardless, it is highly probable that a Groucho-vnd complex is fully functional under an active MAPK 
pathway despite the fact that other Groucho complexes lose functionality when phosphorylated.  
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Neurogenesis pathway 
Using genetic and molecular data, a pathway can be drawn (Figure 5). In early embryogenesis, Dorsal 
signals to vnd first and then ind to initiate expression of each of these genes (Von Ohlen, Doe. 2000). 
During this time, DER also begins signaling in the ventral and intermediate columns. DER signaling 
directly activates ind expression but is not required for initiation of vnd expression. It remains unclear 
whether MAPK downstream of EGF-R activity contributes to VND function. DER signaling is directly 
stimulated by the neuregulin like protein, Vein (Skeath, et al. 1994). Vein is only expressed in the ventral 
and intermediate column and is downregulated beginning in stage 10 embryos (Skeath. 1998). In the 
ventral column, the DER is stimulated by Spitz. Spitz functionality is controlled by the membrane-bound 
protein, Rho (Lanoue and Jacobs, 1999)(Skeath. 1998). In rho mutant embryos, Spitz cannot be properly 
processed for signaling to the DER. Once vnd and ind expression patterns are properly established, msh 
expression begins. The lateral edge of the msh domain is regulated by Dpp expression. Dpp repressed up 
to the far lateral side of the embryo by Dorsal (von Ohlen, Doe. 2000). It is unclear what stimulates the 
expression of msh. Vnd, using groucho as a cofactor, inhibits ind expression to establish the ventral 
domain. Ind represses and positions the ventral boundary of msh although it remains unclear if Groucho 
is a cofactor for ind as well (Von Ohlen. 2007). Also expressed in the intermediate domain is neu3. VND 
has shown the ability to inhibit the expression of this gene when over-expressed into the intermediate 
column (Meyer,H. 2010). The function of neu3 during embryonic development is currently unknown as 
embryos mutant for neu3 have no obvious defects in nervous system development (Meyer,H. 2010). 
However, neu3 is clearly regulated by VND and therefore can be used as a readout of the VND repressor 
function (Meyer, et al. 2010). Once the three domains are established, VND and MSH stimulate and 
maintain A-SC expression. VND does this through the co-activator Dichaete (Zhao,G. 2002). MSH may 
have a similar co-activator but that remains unclear.  
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Fig. 5. Pathway of neuroblast formation in embryogenesis. In the ventral column, Rho 
cleaves spitz which signals to the DER or the DER is directly stimulated by Vein. This 
activates MAPK for Ind expression and possibly Vnd function. Vnd requires cofactors like 
the co-repressor Groucho or the co-activator Dichate. Vnd functions to activate and 
regulate the A-SC, ind, neu3, and neuroblast formation.  
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Chapter 2 
Abstract 
The Drosophila embryonic nervous system develops from an array of neural precursor cells called, 
neuroblasts. These neuroblasts give rise to all the cell types that populate the mature central nervous 
system (CNS). The CNS originates from a bilateraly symmetric neurectoderm that is subdivided into 
three domains along the dorso-ventral (DV) axis. One of these domains is defined by the expression of 
the Homeodomain protein ventral nervous system defective (vnd). Regulation of neuroblast designation 
is very precise and controlled. Extensive research has been done on neuroblast formation along the 
anteroposterior axis, most of which indicates that neuroblast selection within a cluster of 
neurectodermal cells is controlled by segmentation genes. However, much more research is required to 
elucidate the function of genes along the DV axis. Early studies indicate that vnd is required for 
neuroblast formation in the ventral column. Here, we show that vnd function, but not expression, is 
dependent on MAPK activity downstream of Drosophila EGF-R (DER). Specifically, we show that vnd 
activity is eliminated in EGF-R mutant embryos in a stage specific manner by evaluating vnd’s ability to 
inhibit intermediate neuroblast defective (ind), muscle segment homeobox (msh), and the newly 
identified neural tube development player, neu3. Finally, we show that DER functionality in the ventral 
column is entirely dependent on the processing protein rhomboid (rho) in later stage embryos.  
 
Introduction 
During early Drosophila embryogenesis, cell determination signals spawn precise neural progenitor cells 
which then form the neural tube structure. These cells must have proper directionality, timing, and 
cellular properties to develop into a working neural tube. For instance, the embryo must develop a 
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bilateral neurectoderm domain with precise boundaries within each subdomain. In the three 
subdomains, each encodes a different developmental transcription factor: ventral nervous system 
defective (vnd), intermediate nueroblast defective (ind), and muscle segment homeobox (msh). These 
three subdomains run anterior-posterior (AP) and are bilateral along the dorsoventral (DV) axis (Chu,H. 
1998). The neurectoderm must run along the ventral midline and expand dorsally as well as 
anteriorly/posteriorly. In vertebrates, complications in this process can give rise to a variety of 
congenital neurological disorders. This process is highly regulated by a variety of cellular and 
transcriptional signals.  
vnd, ind, and msh expression are initially regulated by the precise activity patterns of three signaling 
pathways: Dorsal, Dpp, and the EGF-R. Dorsal is primarily active in the ventral column with moderate 
activity in the intermediate column and low activity in the dorsal column (Von Ohlen, and Doe. 2000). 
Dpp is just the opposite, showing high expression in the dorsal column, moderate expression in the 
intermediate column, and low expression in the ventral column. The EGF-R is evenly expressed in the 
ventral and intermediate column but is repressed in the dorsal column (Von Ohlen,and Doe. 2000). 
Dorsal knockouts result in the total loss of the entire neurectoderm, at least in part because Dorsal is 
required for the expression of certain genes like vnd and ind (Von Ohlen, and Doe. 2000). Dorsal also 
prevents Dpp from overexpressing itself into the neurectoderm, which would change it into epidermis 
(Von Ohlen, Doe. 2000). Interestingly, even though EGF-R is active in the vnd domain, EGF-R knockouts 
do not result in the loss of vnd expression. It is unknown whether the loss of MAPK activity changes the 
activity of vnd itself (Von Ohlen, Doe. 2000).  
Clearly, vnd is very important in neuroblast formation but exactly how this is accomplished remains 
unclear. Many vnd targets, including ind, Ac, Odd, Prospero, Huckebein, and msh, have been identified. 
Recently, a new vnd target has been characterized: neu3. neu3 encodes meltrin, a matrix 
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metalloprotease. In mice and insects, meltrin is commonly expressed in the peripheral nervous system, 
skeletal muscles, and bones (Meyer, et al. 2010). Its exact function in neurogenisis is unknown, however. 
Its expression pattern in Drosophila embryos mimics that of ind but neu3 does not react like ind when 
EGF-R signaling is lost. In fact, neu3 expression does not change at all in EGF-R mutants. Also, recent 
evidence shows that, like ind, vnd represses neu3 expression in the KrGal4 region when the UAS 
promoter controls vnd (Meyer,H. 2010). This unique feature may make neu3 a good indicator of vnd 
activity in EGF-R mutants. 
EGF-R signaling in Drosophila controls many developmental and metabolic processes. This signaling 
operates through the receptor tyrosine kinase, DER (Skeath. 1998). Like most receptor tyrosine kinases, 
DER requires a ligand for signaling to be transduced. In this case, two ligands are present: spitz and vein. 
Vein is a secreted signaling protein that directly activates DER signaling. Spitz encodes an inactive 
transmembrane protein that, when cleaved and processed from the membrane, becomes a secreted 
signaling molecule. Another membranous protein, rhomboid (Rho), cleaves spitz from the membrane for 
signaling to the DER. Vein/Rho mutant embryos are phenotypically identical to DER mutant embryos but 
not as single mutants (Skeath, et al. 1994), suggesting that both vein and rho act in parallel pathways to 
DER. Recent studies show that in early embryonic development, vein and spitz operate in parallel 
pathways (Skeath, et al. 1994). However, later in development, signaling through the EGF-R is done 
entirely through the rho-spitz pathway (Skeath, et al. 1994). Because ind requires the DER in order to 
begin expression and maintain that expression, it can be concluded that in late stage embryos ind 
patterning is dependent on spitz and rho expression. 
As mentioned earlier, whether vnd function is affected by EGF-R signaling remains unknown. In DER 
mutant embryos neuroblast formation fails to occur in the intermediate column (Skeath, et al. 1994). 
Expression of ind, a gene that plays a crucial role in intermediate column neuroblast formation, is lost in 
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DER mutants (Von Ohlen and Doe, 2000).  Some neuroblast clusters in the medial column form 
incorrectly in DER mutants, indicating that the EGF-R has some influence in neuroblast formation in the 
medial column. Unlike ind, however, vnd expression is not lost in DER mutants. Until recently, whether 
the function of vnd depends on phosphorylation from the EGF-R remained unclear. Groucho, a universal 
co-repressor that binds VND, when phosphorylated, down-regulates its repressive capabilities, thus 
suggesting that phosphorylation of the Groucho-Vnd complex may reduce VND’s ability to repress target 
proteins like IND and meltrin (Cai, et al. 2003). This is, however, unlikely considering that the EGFR is 
active in both the ventral and intermediate domain, and vnd can still repress ind and neu3. It may be 
that Groucho phosphorylation, when Groucho is bound to Vnd, is thwarted by some unknown 
mechanism controlled by a phosphatase. It may also be that Groucho cannot be phosphorylated when 
bound to vnd due to conformational restraints. Regardless, it is highly possible that a Groucho-VND 
complex remains fully functional under an active MAPK pathway despite the fact that other Groucho 
complexes lose functionality when phosphorylated. 
 Our objective in this study has three parts: (1) examine the in vitro phosphorylation of MAPK on VND; 
(2) Characterize vnd, ind, and neu3 phenotypes in rho-/- and DER-/- mutant embryos; and (3) elucidate the 
importance of phosphorylation of VND in its function. Here we hypothesize that (1) VND is 
phosphorylated; (2) IND but not VND or Meltrin portray phenotypes in rho and DER mutants; and (3) 
VND depends on phosphorylation from EGF-R regulated MAPK to repress target genes. 
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Materials and Methods 
In vitro analysis of vnd phosphorylation 
Full length vnd cDNA was constructed along with genetic mutations at S46A, T49A, T256A, and S412A. 
Potential phosphorylation sites were identified using prediction programs motif scan 
(http://scansite.mit.edu) and Kinasephos 
(http://kinasephos.mbc.nctu.edu). Mutagenesis of Vnd cDNA was done in pTOPO4 using the Stratagene 
Quick Change Mutagenesis multi Kit following manufacturer’s directions.  Primers were as follows vnd 
T49A TCCTCCCCAGCCGCGCCGAAGGCCCCG; vnd T46A GTGAGTCCGTCCGCCCCAGCCACGCCG; vnd S412A 
CAGCAGCCCGCCGCTCCGGATAGCACC; and vnd T265A GCCGTGTCGCCCGCGCCAGCGGGCGTT. Then 6x 
His6 genetic constructs were added to the c-terminal end using 
ATGCACCACCACCACCACCACACCACGTCGGCGTCCTTG forward primer and 
CCCAGTCCCGTGAATGCCCAGTTC reverse primer. Fragments were amplified using an annealing 
temperature of 60oC and a melting temperature of 72oC. His6-tagged vnd variants were expressed using 
the Promega TnT rabbit reticulocyte lysate (RRL) expression system. Expressed proteins were pulled 
down using the Promega MagZtm protein purification system. Half of the isolated proteins were applied 
to an in vitro MapKinase phosphorylation system. This system includes 100 units of active MAPK and 200 
µM of ATP. Phosphorylation shifts were visualized on 7.5% SDS-PAGE polyacrylamide gels and silver 
stained. If a shift occurred was observed then RRL’s were split, phosphorylated for 30 minutes or 90 
minutes, and loaded onto an SDS-PAGE with 5 µL sample loading diluted to 20 µL. Shifts were 
revisualized using western blot procedure. Rabbit anti-Vnd antibody was diluted 1:2000 (Sofia 
Georgieva, Russian Academy of Sciences, Moscow, Russia). Antibody-antigen complexes were visualized 
using horseradish peroxidase. 
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Genetics 
Wildtype genetic backgrounds were examined in Yellow-white embryos. Mutant embryonic lines were 
rho7m/tm3ftz, DERf2/cyoftz, Krgal4rho7m/Uasvndrho7m, and UasRhoind/+; Krgal4ind/ind. Rho7m/tm3ftz 
and DERf2/cyoftz fly lines were self crossed (from Bloomington Stock Center). Krgal4rho7m/Tm3ftz males 
were crossed to Uasvndrho7m/Tm3ftz females (McDonald,J.A. 1998). UasRho/UasRho; ind/tm3 males 
were crossed with +/+; Krgal4ind/tm3ftz females (Greenspan, R.J. 1997). All other rho and egfr pathway 
mutant fly lines were gifts from Jocelyn McDonald (Cleveland Clinic) or Amanda Simcox (Ohio State). 
Immuno staining and in situ hybridization 
Rho7m/tm3ftz mutant flies were used in the expression vnd profiling. mRNA of vnd and lacz was 
hybridized to vnd antisense RNA probe using the standard in situ protocol (Tautz, D. 1989). vnd and lacz 
mRNA probe was diluted 1:100. The same experiment was performed on DERf2/cyoftz fly lines. Double 
label immunohistochemistry was performed on rho7m/tm3ftz and DERf2/cyoftz for ind and lacz. The anti-
IND antibody was diluted 1:2000 and the anti-lacz antibody was diluted 1:500 (Von Ohlen, Moses. 2009). 
Double label in situ hybridization was performed with neu3 and lacz mRNA (Meyer, et al. 2010) on 
rho7m/tm3ftz and DERf2/cyoftz fly lines. All mRNA probes were diluted 1:100. In situ stains were 
performed on Wildtype, vnd-, Krgal4xUASvnd, and rho- Krgal4xUASvnd fly lines. The embryos were 
stained for neu3 and examined under a microscope. All probes were diluted 1:100. Wildtype, 
UASrhoxKrGal4, and UASrho/+; Krgal4 ind- were immunostained for vnd to observe vnd expansion into 
the intermediate column. VND antibody was diluted 1:2000. The same embryos were examined using in 
situ staining for neu3.  
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Results 
vnd is phosphorylated in vitro by recombinant MAPK 
Full length VND, when detected on a western blot, showed a fair p42 ERK-induced phosphorylation shift 
(Figure 1A). MAPK phosphorylation shifts for specific point mutations were also observed using a 
western blot procedure (Figure 1B). The bands were detected at the 80 kD range calculated for VND. 
S46A and T49A mutants showed a minor shift whereas T256A and S412A mutants showed a slightly 
larger shift.  Shifts were lost at the 90 minute interval due to active phosphatases present in the RRL.  
 
 
 
 
 
 
 
Fig. 1. VND shows phosphorylation shifts for various point mutations. Full length VND (A) and VND 
with four point mutations (B) show a significant phosphorylation shift. Full length and mutated VND 
were incubated in MAPK for 30 minutes (P30) and 90 min (P90). PFL indicates phosphorylated full 
length VND. 
A 
B 
FL PFL 
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MAPK does not affect vnd expression 
In situ hybridizations reveal that vnd expression is unaffected by Rho-/- mutations (Figure 2A,B). 
However, it is possible that the vein-mediated phosphorylation of vnd pathway is still functional. 
Therefore,  DERf3/cyoftz mutant flies were generated and self-crossed to each other to produce DER 
homozygous mutants. After in situ hybridization of vnd, no obvious phenotype was observed (Figure 2C). 
Whether the lack of phosphorylation affects vnd activity remains unclear. 
 
MapK regulates ind gene expression 
Ind immunostaining using the Rho7m/tm3ftz fly line revealed that Ind expression was relatively 
unaffected in Stage 9 embryos (Figure 3B). In stage 11 embryos, however, Ind expression begins to 
expand into the ventral column where VND would normally inhibit expression (Figure 3E). In the 
DERf3/cyoftz fly line, IND expression was lost in stage 9 embryos (Figure 3C).  However, in stage 11 
embryos, IND expression begins to turn back on. Small pockets of protein patterning can be seen (Figure 
3F). Note that the pockets are mainly in the ventral column, not the intermediate column where IND is 
normally expressed.  
 
 
A B C 
Fig. 2. Stage 9 mutant 
and wildtype embryos 
stained for vnd mRNA 
do not show a distinct 
phenotype. Shown is 
a wild type embryo 
(A), Rho-/- mutant 
embryo (B), and a 
DER-/- mutant embryo 
(C). 
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Neu3 expression is independent of phosphorylation 
In situ stains for neu3 in EGF-R mutants reveal that neu3 expression is independent of the EGF pathway 
(Figure  4). Rho-/- and DER-/- mutant embryos show no specific change from the phenotype of wildtype 
embryos. This indicates that neu3 would be an excellent test gene for vnd overexpression under rho or 
DER mutant backgrounds. Since neu3 has an identical expression pattern to ind and it is immune to 
changes in the EGF pathway, neu3 can be utilized to evaluate vnd function. 
A B C 
D E F 
Fig. 3. Ind is misregulated in EGF-R 
mutants. IND expression is not 
affected in stage 9 Rho-/- mutants (B) 
but IND expansion into the ventral 
column can be seen in stage 11 Rho-/- 
embryos (E). IND expression is 
completely lost in stage 9 DER-/- 
mutants but small pockets of IND 
expression can be seen in the ventral 
column of stage 11 DER-/- embryos. 
Arrows point to IND expansion into 
the ventral column. 
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Fig. 4. In situ stains show that neu3 does not respond to EGF-R mutants. Shown here is wildtype (A), 
rho7m/tm3ftz (B), and DERf2/cyoftz (C). 
 
vnd function is dependent on phosphorylation 
KrGal4Rho/UasvndRho embryonic lines were developed to elucidate the functionality of vnd in a 
background that lacks EGF-R signaling in the ventral column. Rho is a major corner stone for EGF-R 
signaling in the ventral column and does not affect vnd expression. But it remains unknown whether or 
not Rho mutants affect vnd function. To answer this question, KrGal4Rho/UasvndRho mutant embryos 
were first immunovisualized for ind. Wild-type embryos can be seen with the lacz staining (data not 
shown). In a typical KrGal4/Uasvnd embryo, ind is inhibited at stages 9 and 11 in the KrGal4 region (Fig. 
5B). In KrGal4Rho/UasvndRho mutants, however, ind is inhibited in stage 9 embryos but not in stage 11. 
In stage 11 embryos, ind expression can be seen in small pockets in the intermediate column where its 
expression would normally be inhibited. This clearly indicates that vnd’s ability to inhibit ind is 
dependent upon phosphorylation from the vein pathway in early stage embryos. But once vein activity 
A B C 
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drops off, that pathway is no longer active leaving vnd unphosphorylated and unable to inhibit ind 
across the KrGal4 domain. 
 
 
Fig. 5. IND immune-staining shows a loss of vnd inhibition in late stage embryos. Shown is Wildtype (A), 
KrGal4/Uasvnd (B), stage 9 Krgal4rho/Uasvndrho (C), and stage 11 Krgal4rho/Uasvndrho (D). Areas of 
inhibition are shown in brackets. Arrows show pockets of derepression. 
 
A similar phenotypic profile was seen in KrGal4Rho/UasvndRho embryos in situ stained for the meltrin 
gene, neu3. Meltrin is expressed in the intermediate column in the same general pattern as ind. When 
VND is under KrGal4-controlled promotion, VND can also inhibit neu3 (Figure 6B). Again, under mutant 
Stage 9 
Stage 11 
C B A 
D E F 
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rho backgrounds, VND lacks the ability to properly inhibit neu3 in late stage embryos although in early 
stages, it can (Fig. 6C, D). This again indicates that vnd requires the Rho pathway in later stages because 
vein is no longer active. 
 
Fig. 6. In situ staining for neu3 reveals a loss in vnd function in late stage rho mutant embryos. Shown 
are the expression profiles of neu3 in stage 9 or 11 wildtype, vnd-/-, Krgal4/Uasvnd, and 
Krgal4rho/Uasvndrho genetic backgrounds. Brackets show areas of repression and derepression (H). 
 
 
 
A B C D 
E F G H 
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vnd is hyperactive in an ectopic rho background 
To test whether vnd has repressive activities in the intermediate column when rho is ectopically 
expressed, we constructed UasRho/+; Krgal4ind/ind embryonic lines. This expresses rho ectopically 
across the KrGal4 domain, allowing Vnd to be phosphorylated in the intermediate domain in late stage 
embryos. An ind mutant allows vnd to expand into the intermediate domain (Figure 7E,F). To test Vnd 
activity in the intermediate column, we stained for neu3 mRNA. As expected, neu3 is inhibited in the 
UasRho/+; Krgal4ind/ind genetic background (Figure 6C) but not in the UasRho/Krgal4 background (6B). 
 
 
 
A 
F E D 
C B Fig. 7. In situ and antibody 
stains in UasRho/+; 
Krgal4ind/ind embryos 
reveal inhibitory function of 
vnd on neu3 in the 
intermediate column. In situ 
stains for neu3 in wildtype 
(A), UasRho/Krgal4 (B), and 
UasRho/+; krgal4ind/ind 
(C). Zones of inhibition are 
shown in backets. Also 
shown are antibody stains 
for vnd in wildtype (D), 
UasRho/Krgal4 (E), and 
UasRho/+; krgal4ind/ind (E). 
Brackets show areas of 
inhibition (C) of neu3 and 
expansion of VND (F). 
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Discussion 
The EGF pathway plays a central role in Drosophila development. Early studies indicate that an active 
EGF pathway, run through the DER, must be present to induce ind transcription in the intermediate 
column but not vnd in the ventral column. Here we provide evidence that vnd requires phosphorylation 
from a MAPK pathway to maintain it’s repressive activities. Futhermore, we also demonstrate that the 
EGF signals through two distinct pathways with precise timing mechanisms. The first pathway is a two 
step signal involving the Rho-dependent activation of Spitz. Active Spitz is one of the ligands for DER, the 
receptor for EGF. MAPK signals from the DER can then phosphorylate effector proteins for 
transcriptional control. The second pathway involves a ubiquitously expressed ligand, Vein. This ligand is 
expressed evenly in the intermediate and ventral columns until stage 10 when vein signaling shuts down 
leaving the Rho-Spitz pathway as the sole regulator of MAPK activity (Figure 8).  
We provide significant genetic and physical evidence that vnd phosphorylation upregulates its repressive 
activity in the intermediate column. We have identified a MAPK target via in vitro MAPK assays. 
Phosphorylation shifts show that Vnd can be phosphorylated by p42 MAPK in vitro. Mutational analysis 
reveals that S46 and T49 are possible MAPK targets. Further mutational analysis and standardization is 
required to properly indentify the MAPK target but this is the first evidence that VND is phosphorylated 
by p42 MAPK. S46A and T49A double mutational analysis would provide an accurate insight into this 
residue targeting by MAPK. Regardless, VND is clearly capable of undergoing phosphorylation by the 
MAPK downstream from DER. 
Fly lines with DER and Rho knockouts reveal that vnd expression does not depend on phosphorylation 
from MAPK. However, vnd function may require MAPK phosphorylation. Ubitquitously expressed vnd 
requires an active MAPK pathway to inhibit both neu3 and ind in late stage embryos. Ectopically 
expressed vnd with an active MAPK pathway do not share the same phenotype indicating that vnd-
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mediated inhibition of intermediate column proteins by vnd requires phosphorylation. This is further 
confirmed in UasRho/+ ; Krgal4ind/ind mutant embryos where vnd expansion into the intermediate 
column occurred. In this case, neu3 expression is inhibited by vnd.  
ventral intermediate
Rho
Spitz
DER (EGFR)
vnd ind
Neu3
Vein
MapK
?
 
Fig. 8. MapK signaling in the ventral and intermediate columns of Drosophila embryos. Vein signaling is 
deactivated at stage 11. 
 
Late stage embryos seem to show a decrease in vein signaling. Rho mutant embryos, stained for ind, 
reveal an expansion of ind expression into the ventral column. This is evidence that vnd requires 
phosphorylation to prevent ind expansion into this column. This also demonstrates that vein signaling 
shuts down sometime between stage 9 and 11 leaving Rho as the only active EGF pathway. DER 
Inactive at 
stage 11 
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mutants, stained for ind, show a loss of function phenotype in stage 9 embryos as seen in figure 3. 
However, in stage 11 embryos, ind expression begins to turn back on. Interestingly, the small pockets of 
ind expression are only seen in the ventral column, not the intermediate column. This provides evidence 
that ind expression is activated by an unknown activator in the intermediate column. This activator 
requires phosphorylation in the intermediate column to initiate ind expression in wildtype embryos. It is 
also very possible that this activator is repressed by phosphorylated vnd and expands into the ventral 
column when vnd is not functional. This would explain why ind expression is seen in the ventral column 
in DER mutant embryos only in this case, phosphorylation of the activator, is not required to induce ind 
expression. 
Recent studies have indicated that phosphorylation of the vnd co-repressor, Groucho, down regulates 
Groucho and thus vnd activity (Cornell, Von Ohlen. 2000; Paroush. Personal Communications). The 
results of this study partly contradict this. It has been found that phosphorylation of Groucho by EGFR is, 
at the very least, partly required for ind promotion (Paroush. Personal Communications). In fact, ras 
mutants, which show a similar ind phenotype to DER mutants, are partly restored when Groucho is 
knocked-out in tandem (Paroush. Personal Communications). However, because the phenotype is not 
fully restored, a Groucho-independent mechanism must induce ind expression, and that mechanism 
requires signals from the EGF-R. Futhermore, Groucho appears to maintain its phosphorylated state 
even when EGF-R signaling has ceased. This indicates that Groucho remains inactive for several hours 
after phosphorylation from MAPK. If vnd inhibition of neu3 and ind depends upon Groucho function, 
then phosphorylation of Groucho from the vein pathway should continue to have an effect on Groucho 
function well into stage 11 embryos. We did not see that effect, which indicates that either vnd 
inhibition of ind and neu3 is a Groucho-independent process or Groucho phosphorylation is inhibited by 
an unknown mechanism in the ventral column. It is possible that Groucho cannot be phosphorylated 
due to the heterodimeric conformation it forms when complexed to vnd. It is also possible that Groucho 
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is stoichiometrically inhibited and does not play a significant role in the vnd-mediated inhibition of ind 
and neu3. Clearly, more research is required to elucidate this contradiction. 
In conclusion, vnd inhibition of ind and neu3 is a mechanism under the control of MAPK signaling. There 
is a strong possibility that vnd function is partially or entirely controled by the EGF pathway despite the 
fact that vnd expression is not. Signaling to the DER is done through two pathways: 1. Spitz is cleaved 
from the membrane by Rho which signals to the DER; and 2. Vein signals directly to the DER. The first 
pathway is active in the ventral column, and the second pathway is active in both the ventral and 
intermediate column but becomes inactive sometime during stage 10. This pathway is likely important 
in vnd-controled regulation of neuroblast formation in the ventral column.  
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